NCT00252642View on ClinicalTrials.gov

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Hepatitis CCirrhosisFibrosis
Interventions
DRUG

Peginterferon Alpha-2a

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Virginia Commonwealth University

OTHER

NCT00252642 - Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C | Biotech Hunter | Biotech Hunter